| 前收市價 | 4.7850 |
| 開市 | 4.7970 |
| 買盤 | 4.7360 x 無 |
| 賣出價 | 4.8150 x 無 |
| 今日波幅 | 4.7970 - 4.8000 |
| 52 週波幅 | 4.7850 - 9.5190 |
| 成交量 | |
| 平均成交量 | 59 |
| 市值 | 705.648M |
| Beta 值 (5 年，每月) | 1.21 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.1600 |
| 業績公佈日 | 2023年11月01日 - 2023年11月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 56.67 |
InvestorPlace3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
Investing in biotech stocks is challenging even when you’re investing in established companies with commercially available drugs and expansive pipelines. And investing in up-and-coming biotech stocks is only for the most risk-tolerant investors. When investing in the biotech sector, you’re speculating on future outcomes rather than a company’s financial performance. That’s because in many cases, these up-and-comers are long on potential but short on revenue and – more importantly – profit. And a
Insider MonkeyIs it Still Worthy to Invest in Adaptive Biotechnologies (ADPT)?
Aristotle Atlantic Partners, an investment management firm, released its second quarter 2023 investor letter, a copy of which can be downloaded here. For the second quarter of 2023, Aristotle Atlantic’s Core Equity Composite posted a total return of 9.29 % gross of fees (9.18% net of fees), outperforming the S&P 500 Index, which recorded a […]
Insider MonkeyViking Global’s Performance, AUM, and Long-Term Stock Picks
In this article, we discuss Viking Global’s performance, AUM, and 10 long-term stock picks. To skip the detailed analysis, performance history, and investment philosophy of Andreas Halvorsen’s Viking Global, go directly to Viking Global’s 5 Long-Term Stock Picks. Andreas Halvorsen is the co-founder of Viking Global and is currently the CEO of the firm. He […]
